These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28713573)

  • 1. A monograph proposing the use of canine mammary tumours as a model for the study of hereditary breast cancer susceptibility genes in humans.
    Goebel K; Merner ND
    Vet Med Sci; 2017 May; 3(2):51-62. PubMed ID: 28713573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of HOX gene expression in canine mammary tumour cell lines from spontaneous tumours.
    DeInnocentes P; Perry AL; Graff EC; Lutful Kabir FM; Curtis Bird R
    Vet Comp Oncol; 2015 Sep; 13(3):322-36. PubMed ID: 24034269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of canine and human breast cancer.
    Owen LN
    Invest Cell Pathol; 1979; 2(4):257-75. PubMed ID: 396282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours.
    Kumaraguruparan R; Prathiba D; Nagini S
    Res Vet Sci; 2006 Oct; 81(2):218-24. PubMed ID: 16740286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue.
    Hsu WL; Huang YH; Chang TJ; Wong ML; Chang SC
    Vet J; 2010 Jun; 184(3):351-6. PubMed ID: 19944633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours.
    Cassali GD; Gobbi H; Malm C; Schmitt FC
    Cytopathology; 2007 Jun; 18(3):191-6. PubMed ID: 17573766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine mammary tumours as a model to study human breast cancer: most recent findings.
    Queiroga FL; Raposo T; Carvalho MI; Prada J; Pires I
    In Vivo; 2011; 25(3):455-65. PubMed ID: 21576423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of canine mammary cells with stem cell properties and tumour-initiating potential.
    Cocola C; Anastasi P; Astigiano S; Piscitelli E; Pelucchi P; Vilardo L; Bertoli G; Beccaglia M; Veronesi MC; Sanzone S; Barbieri O; Reinbold RA; Luvoni GC; Zucchi I
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():214-7. PubMed ID: 19754572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
    Aloraifi F; Boland MR; Green AJ; Geraghty JG
    Surg Oncol; 2015 Jun; 24(2):100-9. PubMed ID: 25936246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
    Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
    BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant canine mammary tumours: Preliminary genomic insights using oligonucleotide array comparative genomic hybridisation analysis.
    Santos M; Dias-Pereira P; Williams C; Lopes C; Breen M
    Vet J; 2017 Apr; 222():68-71. PubMed ID: 28392153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.
    Veldhoen N; Watterson J; Brash M; Milner J
    Br J Cancer; 1999 Oct; 81(3):409-15. PubMed ID: 10507764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective: prostate cancer susceptibility genes.
    Simard J; Dumont M; Soucy P; Labrie F
    Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
    Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
    Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of cancer stem cells in canine mammary tumors.
    Rybicka A; Król M
    Acta Vet Scand; 2016 Dec; 58(1):86. PubMed ID: 27993142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology.
    London CA; Gardner H; Zhao S; Knapp DW; Utturkar SM; Duval DL; Chambers MR; Ostrander E; Trent JM; Kuffel G
    Vet Comp Oncol; 2023 Dec; 21(4):565-577. PubMed ID: 37778398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
    Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
    Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Swiss Canine Cancer Registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008.
    Grüntzig K; Graf R; Hässig M; Welle M; Meier D; Lott G; Erni D; Schenker NS; Guscetti F; Boo G; Axhausen K; Fabrikant S; Folkers G; Pospischil A
    J Comp Pathol; 2015; 152(2-3):161-71. PubMed ID: 25824119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.